Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
解鎖市場時間軸與訊號動態
過去 90 日內有 424 個訊號。
此公司進入各市場的次序 — 由最舊至最新
Discover your next job opportunity in Pune, India
Join our growing IT teams in Pune, India
註冊以查看完整訊號動態
Edwards Lifesciences 的國際擴張與競爭對手的比較
Edwards Lifesciences你長條顯示所比較各公司之間的相對規模。
5 項指標| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Edwards Lifesciences你 | 38 | 0 | +18% | 399 | 32 |
急速擴張 — 過去 90 日內開放了 461 個職位，較上一期上升 97%。 以 Sales 為主，集中於 法國。
Pune City, Maharashtra, India · 前日
Engineer II, AI/Machine Learning
Pune City, Maharashtra, India · 前日
Engineer II, AI/Machine Learning
Greater Besancon Area · 前日
Field Clinical Specialist, Mitral Therapies - Région Nord Est
整個技術架構共偵測到 59 項技術。
於 40 個市場進行 4 個活躍廣告活動。
進行中
進行中
進行中過去 90 日內有 3 則提及。
愛德華生命科學在香港成功完成首批三尖瓣反流患者治療,使用PASCAL Precision系統,擴展2025年推出的二尖瓣應用範圍。
Edwards Lifesciences公佈COMMENCE試驗10年結果,顯示RESILIA組織結構性瓣膜退化免除率達97.9%,支持全球超過50萬患者的長期耐用性。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Edwards Lifesciences 業務、市場及增長訊號的快速解答。
